Oz Azam (Tmunity)
Months after Tmunity ground to a halt on clinical hold, cell therapy pioneer Oz Azam is jumping to a stealth startup
Eight months after execs at Tmunity told us in an exclusive report that the FDA had slapped a clinical hold on their pipeline programs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
